Close

MuriGen Therapeutics

What

Drug discovery

CEO

Nick Samaras

Investment Director

Michael Panaccio

Investment Date

December 2006

MuriGen Therapeutics is a drug discovery and development company established by the Walter and Eliza Hall Institute of Medical Research (WEHI).

MuriGen is building a portfolio of novel drugs for unmet medical needs across a number of therapeutic areas including cancer, arthritis, thrombocytopenia, inflammation, epilepsy and thalassemia.